ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

Rhea-AI Summary

ProSomnus, Inc. (OSA) delays 2023 Q4 and full year financial results release and investor call, rescheduled for March 26, 2024. The company also cancels attendance at the Roth Conference.

Positive

• None.

Negative

• Delayed release of financial results may indicate potential issues or challenges within the company's financial performance.
• Cancellation of attendance at the Roth Conference could impact networking and business development opportunities for ProSomnus, Inc.

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has postponed the release of its 2023 fourth quarter and full year financial results and the related investor conference call. The rescheduled call will be held after market close on Tuesday, March 26, 2024 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Registration and dial-in information can be found on the investor relations website. Additionally, the Company will not be attending the Roth Conference.

About ProSomnus
ProSomnus (NASDAQ: OSA) is the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. To learn more, visit www.ProSomnus.com.

Investor Contact
Mike Cavanaugh
ICR Westwicke
Phone: +1.617.877.9641
Email: Mike.Cavanaugh@westwicke.com

Media Contact
Heather Whalen
ProSomnus
Phone: +1.925.360.2990
Email: HWhalen@ProSomnus.com

FAQ

Why did ProSomnus, Inc. (OSA) postpone the release of its 2023 fourth quarter and full year financial results?

ProSomnus, Inc. (OSA) delayed the release of its financial results for the fourth quarter of 2023 and the full year, along with the related investor conference call. The new date for the call is March 26, 2024.

When will the rescheduled investor conference call take place for ProSomnus, Inc. (OSA)?

The rescheduled investor conference call for ProSomnus, Inc. (OSA) will be held after market close on Tuesday, March 26, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Why is ProSomnus, Inc. (OSA) not attending the Roth Conference?

ProSomnus, Inc. (OSA) has decided not to attend the Roth Conference, impacting its participation in networking and business development opportunities at the event.